These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 33345329)

  • 21. Chronic cat allergen exposure induces a TH2 cell-dependent IgG4 response related to low sensitization.
    Renand A; Archila LD; McGinty J; Wambre E; Robinson D; Hales BJ; Thomas WR; Kwok WW
    J Allergy Clin Immunol; 2015 Dec; 136(6):1627-1635.e13. PubMed ID: 26371841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-4 receptor α blockade prevents sensitization and alters acute and long-lasting effects of allergen-specific immunotherapy of murine allergic asthma.
    Russkamp D; Aguilar-Pimentel A; Alessandrini F; Gailus-Durner V; Fuchs H; Ohnmacht C; Chaker A; de Angelis MH; Ollert M; Schmidt-Weber CB; Blank S
    Allergy; 2019 Aug; 74(8):1549-1560. PubMed ID: 30829405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma.
    Hesse L; Nawijn MC
    Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of CRTh2 expression on allergen-specific T cells following peptide immunotherapy.
    Rudulier CD; Tonti E; James E; Kwok WW; Larché M
    Allergy; 2019 Nov; 74(11):2157-2166. PubMed ID: 31077596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allergens and Adjuvants in Allergen Immunotherapy for Immune Activation, Tolerance, and Resilience.
    Jensen-Jarolim E; Roth-Walter F; Jordakieva G; Pali-Schöll I
    J Allergy Clin Immunol Pract; 2021 May; 9(5):1780-1789. PubMed ID: 33753052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel mechanisms in immune tolerance to allergens during natural allergen exposure and allergen-specific immunotherapy.
    van de Veen W; Wirz OF; Globinska A; Akdis M
    Curr Opin Immunol; 2017 Oct; 48():74-81. PubMed ID: 28888176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel adjuvants in allergen-specific immunotherapy: where do we stand?
    Lin YJ; Zimmermann J; Schülke S
    Front Immunol; 2024; 15():1348305. PubMed ID: 38464539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A role for IL-10-mediated HLA-DR7-restricted T cell-dependent events in development of the modified Th2 response to cat allergen.
    Reefer AJ; Carneiro RM; Custis NJ; Platts-Mills TA; Sung SS; Hammer J; Woodfolk JA
    J Immunol; 2004 Mar; 172(5):2763-72. PubMed ID: 14978075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Passive Prophylactic Administration with a Single Dose of Anti-Fel d 1 Monoclonal Antibodies REGN1908-1909 in Cat Allergen-induced Allergic Rhinitis: A Randomized, Double-Blind, Placebo-controlled Clinical Trial.
    Shamji MH; Singh I; Layhadi JA; Ito C; Karamani A; Kouser L; Sharif H; Tang J; Handijiev S; Parkin RV; Durham SR; Kostic A; Orengo JM; DeVeaux M; Kamal M; Stahl N; Yancopoulos GD; Wang CQ; Radin AR
    Am J Respir Crit Care Med; 2021 Jul; 204(1):23-33. PubMed ID: 33651675
    [No Abstract]   [Full Text] [Related]  

  • 30. AIT: New Avenues in Allergen Immunotherapy.
    Pfützner W; Möbs C
    Handb Exp Pharmacol; 2022; 268():135-149. PubMed ID: 34268615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Albumins represent highly cross-reactive animal allergens.
    Liu Z; Trifonova D; Tulaeva I; Riabova K; Karsonova A; Kozlov E; Elisyutina O; Khaitov M; Focke-Tejkl M; Chen TH; Karaulov A; Valenta R
    Front Immunol; 2023; 14():1241518. PubMed ID: 37928538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of the aryl hydrocarbon receptor improves allergen-specific immunotherapy of murine allergic airway inflammation: a novel adjuvant option?
    Heine S; Alessandrini F; Grosch J; Graß C; Heldner A; Schnautz B; Grosch J; Buters J; Slusarenko BO; Krappmann D; Fallarino F; Ohnmacht C; Schmidt-Weber CB; Blank S
    Front Immunol; 2024; 15():1397072. PubMed ID: 38915403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fel d 1-derived synthetic peptide immuno-regulatory epitopes show a long-term treatment effect in cat allergic subjects.
    Couroux P; Patel D; Armstrong K; Larché M; Hafner RP
    Clin Exp Allergy; 2015 May; 45(5):974-981. PubMed ID: 25600085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fel d 4, a cat lipocalin allergen.
    Smith W; Butler AJ; Hazell LA; Chapman MD; Pomés A; Nickels DG; Thomas WR
    Clin Exp Allergy; 2004 Nov; 34(11):1732-8. PubMed ID: 15544598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunotherapies in the treatment of immunoglobulin E‑mediated allergy: Challenges and scope for innovation (Review).
    Yadav S; Singh S; Mandal P; Tripathi A
    Int J Mol Med; 2022 Jul; 50(1):. PubMed ID: 35616144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of an allergen in dog dander that cross-reacts with the major cat allergen, Fel d 1.
    Reininger R; Varga EM; Zach M; Balic N; Lindemeier AD; Swoboda I; Grönlund H; van Hage M; Rumpold H; Valenta R; Spitzauer S
    Clin Exp Allergy; 2007 Jan; 37(1):116-24. PubMed ID: 17210049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allergens as immunomodulatory proteins: the cat dander protein Fel d 1 enhances TLR activation by lipid ligands.
    Herre J; Grönlund H; Brooks H; Hopkins L; Waggoner L; Murton B; Gangloff M; Opaleye O; Chilvers ER; Fitzgerald K; Gay N; Monie T; Bryant C
    J Immunol; 2013 Aug; 191(4):1529-35. PubMed ID: 23878318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of allergen immunotherapy supporting its disease-modifying effect.
    Bumbacea RS; Boustani R; Panaitescu C; Haidar L; Buzan MR; Bumbacea D; Laculiceanu A; Cojanu C; Spanu D; Agache I
    Immunotherapy; 2022 Jun; 14(8):627-638. PubMed ID: 35416072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of Fel d 1-derived T-cell peptides on upper and lower airway outcome measurements in cat-allergic subjects.
    Alexander C; Tarzi M; Larché M; Kay AB
    Allergy; 2005 Oct; 60(10):1269-74. PubMed ID: 16134993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human T and B cell immune responses to Fel d 1 in cat-allergic and non-cat-allergic subjects.
    Mark PG; Segal DB; Dallaire ML; Garman RD
    Clin Exp Allergy; 1996 Nov; 26(11):1316-28. PubMed ID: 8955581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.